Barinthus Biotherapeutics
BRNS----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Barinthus Biotherapeutics(BRNS) predict that the EPS is -0.14 (+71.43%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EPSExceed expectations
-0.1471.43%
-0.3626.53%
+0.220044.90%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf